Knowledge (XXG)

User talk:Committed molecules

Source 📝

364:- please do read that and keep it in mind. Passion is a double-edged sword in Knowledge (XXG). It brings people here and makes them want to contribute, but passion can push people to want to ignore our policies and guidelines and leads people into arguments with other editors. So if you run into editors who are not as enthusiastic as you are about CoQ, please keep that in mind. We all need to leave our passions at the door as much as we can when we log in here (me included) and try to follow the policies and guidelines as we work. Good luck! 232:- you have edited on exactly one topic here in WP. Thanks for clarifying that you don't believe you have a COI. Based on what you write, you appear to be an academic scientist or doctor who studies CoQ/ubiquinol. Is that right? If so, I want to make sure you are aware of the following part of COI: 258:
Thank you Jytdog. I am a researcher. It is obvious in my proposal that I did not write about my own work. Each source is by different author and I am happy to look for other sources. Infact I do not have any publications, I am not here to advertise and so I do not have any conflict of interest. I am
130:
is not what I am because my edits go back to 2010. I was driven away by reverting editors so I left Knowledge (XXG). I am not a disruptive editor which is why I just left whenever I editor kept undoing my changes. I do not think editing only in a topic of my interest and knowledge makes me a single
94:
Disclosure is the most important, and first, step. Would you please let me know if you have anything to disclose with regard to Terms of Use as described above, or any relationship that may constitute a COI (for example, you might work for a company that makes or sells ubiquinol and CoQ) I am not
70:
At the moment, it really looks like any detail (especially when supported by one or two primary papers) is not appropriate for this subject. I understand that you regard it is important, but that doesn't mean that wiki is the correct place for this information - I think a digest/surveys paper in a
295:
Thanks. I will prefer to go within wikipedia policies to reach a resolution not editwar with Alexbrn. Let me come up with more sources on talkpage. My only problem is that editors who want to dispute should respond on talkpage sooner or later not just wait for me to add it to article and revert.
61:
The article should follow wiki policies. If appropriate material doesn't exist for what you'd like to write, sorry but it shouldn't appear in wiki. Seems like Ubiquitol is an example if this - it is too early in the field for it to be reported in a clear, factual manner in textbooks or official
359:
as you will. One more thing to keep in mind. Often when I start talking to people, as I did with you, it is not clear if the editor is driven by a conflict of interest, or is "just" a fan or advocate for whatever the topic is. Before I leave this, let me point you to our excellent essay on
263:
is not neutrally covering everything. It is a good thing you asked me this so that I can clarify it. I will go with posting the content on the talk page. You know that is what I did when I came back here but no one responded. Alexbrn reverted only when I added it to article after no reponse.
177:
Did you not read what I replied above? I have no connection to the sources or world of ubiquinol whatever you mean by that. I search for them over the internet. Ubiquinol is of my interest and my field of study and I want to improve this article before I move on to others. Is it just your
280:
Thanks much, all good to go on this COI front - there is no bar to you editing directly (although since there is content under dispute/debate, talk page discussion is indeed the way to go at this point. Thanks for being gracious throughout the discussion. See you on article Talk pages!
107:
that constitutes a COI. You can answer how ever you wish, but if there is a relationship, please disclose it. After you respond (and you can just reply below), perhaps we can talk a bit about editing Knowledge (XXG), to give you some more orientation to how this place works. Thanks!
321:
Sure. I do suggest that you broaden your editing beyond CoQ and Ubiquinol. I should let you know that I have looked deeply into the literature on CoQ and Ubiquinol and there is not a lot more that you are going to be able to add. Human studies have not borne out the promise of
131:
purpose or less credible. It makes sense that I am editing what I know well. So I do not think I have any conflict of interest. Now after better understanding of making edits and rules against editwar, I have come back without fighting over what I want to add and I am following
90:
Knowledge (XXG) is a widely-used reference work and managing conflict of interest is essential for ensuring the integrity of Knowledge (XXG) and retaining the public's trust in it. As in academia, COI is managed here in two steps - disclosure and a form of peer review.
65:
It looks like you've been reverting other peoples edits, where they are trying to conform to policy. If you get a reputation for repeating this, it just damages your position. Reverts are really for fixing damage/vandalism/graffiti, not for changing back to disputed
135:. If you see my recent edits on Ubiquinol, I was reverted on one section so I decided to add totally different data and with new references. I am not related to those sources as it is apparent I searched for them over the internet 326:
and animal studies; the whole antioxidant hypothesis has not worked out in humans so far. Because Knowledge (XXG) is evidence-based there is not a lot more we are going to be able to say.
240:. If you would like to add content to WP about your work, I suggest you post the content on the Talk page and ask for others' thoughts on it. Also, please do read 244:. If you have questions about MEDRS and why we hold a high standard for content about health, I'd be happy to discuss that with you. Thanks again for talking! 139:
Alexbrn's comments but it appears he is still not happy. I want to thank you for keeping watch on this page. I will keep looking for more references as well. --
237: 62:
guidelines because knowledge about it is uncertain and changing/evolving quickly. That kind of knowledge on a medical item is clearly again wiki policies.
341:
I will try to edit other articles once I have more time and topics of interest. I understand that wikipedia would not allow the reference in even if I
57:
Hi, DrPixie here. Got your message re the bias note, but it seems other people are also very concerned about this article. Important things to note:
25:
for discussion/explanation about the changes to the Ubiquinol article. I'll keep an eye on that page, if you want to discuss improving the article.
127: 233: 345:
give references to promising research on human studies. I have gone with a pubmed reference with a new proposal on talkpage. --
111:
You can reply here - I am watching this page. Once you do, we can take it from there. Thanks in advance for talking!
379: 346: 297: 265: 207: 179: 140: 40: 158:
could I ask you to clarify what connection (if any) you have to the world of Ubiquinol and/or coenzyme Q
361: 100: 241: 197: 167: 76: 48: 30: 369: 331: 286: 249: 116: 229: 155: 132: 22: 228:
Thanks for replying, Committed molecules. I have to correct you - your account is a
387: 373: 354: 335: 305: 290: 273: 253: 215: 201: 187: 171: 148: 120: 80: 52: 34: 193: 163: 72: 44: 26: 365: 327: 282: 245: 112: 260: 206:
You are welcome. I am merging this section you did not skip your heading. --
178:
disagreement on standards of references that leads you to believe I do? --
43:
so people have some idea of your background, expertise, and interests.
378:
Thanks. I shall be on the side of balanced wikipedia articles. --
192:
No, I didn't see what you'd put before. Thanks for clarifying!
39:
Also, please consider adding something to your user page
259:trying to improve the subject I know and I think 238:Knowledge (XXG):Conflicts of interest (medicine) 126:Hello Jytdog, you seem to be a neutral editor. 71:reputable journal is where this should appear. 103:policy) but please disclose if you have some 8: 99:(anonymity is strictly protecting by out 128:Knowledge (XXG):Single-purpose account 7: 234:Writing about yourself and your work 17:Ubiquinol - excess content removal 14: 1: 95:asking you to disclose your 81:03:43, 31 August 2014 (UTC) 408: 388:20:36, 24 July 2015 (UTC) 374:20:24, 24 July 2015 (UTC) 355:20:08, 24 July 2015 (UTC) 336:19:55, 24 July 2015 (UTC) 306:19:43, 24 July 2015 (UTC) 291:19:33, 24 July 2015 (UTC) 274:19:29, 24 July 2015 (UTC) 254:13:32, 24 July 2015 (UTC) 216:12:37, 24 July 2015 (UTC) 202:12:36, 24 July 2015 (UTC) 188:12:33, 24 July 2015 (UTC) 172:12:26, 24 July 2015 (UTC) 149:12:11, 24 July 2015 (UTC) 121:12:58, 23 July 2015 (UTC) 53:11:40, 14 July 2014 (UTC) 35:11:38, 14 July 2014 (UTC) 383: 350: 301: 269: 211: 183: 144: 41:User:Committed molecules 86:Comments and Question 380:Committed molecules 347:Committed molecules 298:Committed molecules 266:Committed molecules 208:Committed molecules 180:Committed molecules 141:Committed molecules 399: 154:In the light of 407: 406: 402: 401: 400: 398: 397: 396: 161: 88: 21:Hi, please see 19: 12: 11: 5: 405: 403: 395: 394: 393: 392: 391: 390: 319: 318: 317: 316: 315: 314: 313: 312: 311: 310: 309: 308: 223: 222: 221: 220: 219: 218: 159: 152: 151: 87: 84: 68: 67: 63: 23:Talk:Ubiquinol 18: 15: 13: 10: 9: 6: 4: 3: 2: 404: 389: 385: 381: 377: 376: 375: 371: 367: 363: 358: 357: 356: 352: 348: 344: 340: 339: 338: 337: 333: 329: 325: 307: 303: 299: 294: 293: 292: 288: 284: 279: 278: 277: 276: 275: 271: 267: 262: 257: 256: 255: 251: 247: 243: 239: 235: 231: 227: 226: 225: 224: 217: 213: 209: 205: 204: 203: 199: 195: 191: 190: 189: 185: 181: 176: 175: 174: 173: 169: 165: 157: 150: 146: 142: 138: 134: 129: 125: 124: 123: 122: 118: 114: 109: 106: 102: 98: 92: 85: 83: 82: 78: 74: 64: 60: 59: 58: 55: 54: 50: 46: 42: 37: 36: 32: 28: 24: 16: 342: 323: 320: 153: 136: 110: 105:relationship 104: 96: 93: 89: 69: 56: 38: 20: 362:WP:ADVOCACY 236:as well as 162:. Thanks, 261:Ubiquinol 101:WP:OUTING 324:in vitro 242:WP:MEDRS 97:identity 194:Alexbrn 164:Alexbrn 73:Drpixie 45:Drpixie 27:Drpixie 366:Jytdog 328:Jytdog 283:Jytdog 246:Jytdog 230:WP:SPA 156:WP:COI 113:Jytdog 137:after 133:WP:DR 66:text. 384:talk 370:talk 351:talk 332:talk 302:talk 287:talk 270:talk 250:talk 212:talk 198:talk 184:talk 168:talk 145:talk 117:talk 77:talk 49:talk 31:talk 386:) 372:) 353:) 343:do 334:) 304:) 296:-- 289:) 272:) 264:-- 252:) 214:) 200:) 186:) 170:) 160:10 147:) 119:) 79:) 51:) 33:) 382:( 368:( 349:( 330:( 300:( 285:( 268:( 248:( 210:( 196:( 182:( 166:( 143:( 115:( 75:( 47:( 29:(

Index

Talk:Ubiquinol
Drpixie
talk
11:38, 14 July 2014 (UTC)
User:Committed molecules
Drpixie
talk
11:40, 14 July 2014 (UTC)
Drpixie
talk
03:43, 31 August 2014 (UTC)
WP:OUTING
Jytdog
talk
12:58, 23 July 2015 (UTC)
Knowledge (XXG):Single-purpose account
WP:DR
Committed molecules
talk
12:11, 24 July 2015 (UTC)
WP:COI
Alexbrn
talk
12:26, 24 July 2015 (UTC)
Committed molecules
talk
12:33, 24 July 2015 (UTC)
Alexbrn
talk
12:36, 24 July 2015 (UTC)

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.